- RESEARCH HIGHLIGHT
- 15 May 2026
The personalized treatment encourages the immune system to attack the tumours called glioblastomas.
Trending
- Scientists shut down cancer DNA repair to overcome drug resistance
- The future is not always uniform: rethinking radiotherapy through spatial fractionation
- CD70 drives cSCC growth by linking DNA damage response, inflammation, and tumor–stromal signaling
- 76 Real-World Safety of Trastuzumab Deruxtecan in HER2-Low Metastatic Breast Cancer: Insights From US Community Oncology Practices
- 75 Trastuzumab Deruxtecan in HER2-Low Metastatic Breast Cancer: Real-World Treatment Patterns and Outcomes From Community Oncology Settings
- Combination of paricalcitol with chemotherapy shows promise in phase 1 study of metastatic pancreatic cancer
- Asciminib May Offer Longer, Better Life in Frontline CML Care
- Hetairos is a histology-based artificial intelligence model for predicting central nervous system tumor methylation subtypes
Thursday, June 11
